Cargando…
Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality
Trimethylamine-N-oxide (TMAO), a gut-microbiota-dependent metabolite generated from its dietary precursors such as choline, has been identified as an independent risk factor for atherosclerosis. Metformin is the most widely used drug for the treatment of type 2 diabetes (T2D), which has therapeutic...
Autores principales: | Su, Chunyan, Li, Xingxing, Yang, Yuxin, Du, Yu, Zhang, Xiumin, Wang, Li, Hong, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363624/ https://www.ncbi.nlm.nih.gov/pubmed/34389700 http://dx.doi.org/10.1038/s41387-021-00169-w |
Ejemplares similares
-
Dietary Methionine Restriction Alleviates Choline-Induced Tri-Methylamine-N-Oxide (TMAO) Elevation by Manipulating Gut Microbiota in Mice
por: Lu, Manman, et al.
Publicado: (2023) -
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota
por: Ma, Shu-Rong, et al.
Publicado: (2022) -
Urinary TMAO Levels Are Associated with the Taxonomic Composition of the Gut Microbiota and with the Choline TMA-Lyase Gene (cutC) Harbored by Enterobacteriaceae
por: Dalla Via, Alessandro, et al.
Publicado: (2019) -
Effects of Perfluorooctanoic Acid on Gut Microbiota and Microbial Metabolites in C57BL/6J Mice
por: Gao, Bei, et al.
Publicado: (2023) -
Lycium barbarum Oligosaccharides Alleviate Hepatic Steatosis by Modulating Gut Microbiota in C57BL/6J Mice Fed a High-Fat Diet
por: Li, Mengjie, et al.
Publicado: (2023)